We are very grateful to the supporters of the 35th International Symposium on ALS/MND, held in Montreal, Canada and Virtually on 6-8 December 2024:
Headline Sponsor
Mitsubishi Tanabe Pharma America and Mitsubishi Tanabe Pharma Canada
Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), based in Toronto, Canada is a wholly owned subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA). MTP-CA’s entrepreneurial spirit and patient-first philosophy are deeply rooted in a legacy set by its parent company, Mitsubishi Tanabe Pharma Corporation (MTPC) in Japan, which touts a storied reputation more than 300 years in the making. For more information, please visit: www.mt-pharma-ca.com.
Key Sponsor
LifeArc
LifeArc is a self-funded, not-for-profit medical research charity. We take science ideas out of the lab and help turn them into medical breakthroughs that can be life-changing for patients. We have been doing this for more than 25 years and our work has resulted in five licensed medicines, including drugs to treat cancer and Alzheimer’s, and a diagnostic for antibiotic resistance. LifeArc’s Motor Neuron Disease Translational Challenge is focused on accelerating healthcare innovation for people living with MND/ALS. Find out more about LifeArc and its work in motor neuron disease at www.lifearc.org